Psycho-Education with Problem Solving (PEPS) therapy for personality disorder

ISRCTN ISRCTN70660936
DOI https://doi.org/10.1186/ISRCTN70660936
Secondary identifying numbers HTA 08/53/06
Submission date
30/11/2009
Registration date
03/12/2009
Last edited
16/01/2018
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

STUDY SUMMARY tab on http://www.peps-trial.co.uk/

Study website

Contact information

Prof Mary McMurran
Scientific

Institute of Mental Health
University of Nottingham
The Sir Colin Campbell Building
Triumph Road
Nottingham
NG7 2TU
United Kingdom

Study information

Study designMulticentre two-arm parallel group randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeTreatment
Participant information sheet INFORMATION SHEETS tab on http://www.peps-trial.co.uk/
Scientific titlePsycho-Education with Problem Solving (PEPS) therapy for adults with personality disorder: a community-based randomised controlled trial
Study acronymPEPS
Study objectivesThe purpose of the trial is to evaluate the effectiveness of PEPS therapy compared with treatment as usual in improving social functioning in community based adults with personality disorder.

Please note, as of 23/06/2011 various updates have been made to this trial and can be found under this date of update in the relevant fields below.
Ethics approval(s)South East Wales Research Ethics Committee Panel C approved on 13/11/2009 (ref: 09/WSE03/48)
Health condition(s) or problem(s) studiedPersonality disorder
InterventionPsycho-education combined with problem solving (PEPS) therapy is a complex cognitive-behavioural intervention that integrates individual and group therapies. Psycho-education consists of up to 4 sessions of an individual collaborative dialogue designed to build a rapport with patients, inform them about their personality disorder, discuss its effects on interpersonal relationships and social functioning, and enhance motivation for therapy. Problem solving therapy is a 12-session group intervention designed to teach people strategies for solving interpersonal problems. Throughout the twelve week problem solving therapy group sessions, participants are offered additional, optional fortnightly individual support sessions with a group facilitator.

PEPS therapy will be compared with treatment as usual. (Added 23/06/2011; previous intervention for this point can be found below).

Follow-up assessments for all participants will be completed after the initial treatment phase (weeks 5 - 10), immediately after the second treatment phase (during weeks 24 - 26) and again four and twelve months after the end of the intervention.

Previous intervention:

PEPS therapy will be compared with a standardised form of 'treatment as usual' which will include an initial care planning session with a mental health worker, including plans for future contact with services and details of alternative sources of help and support, with a follow-up session after approximately 4 weeks and a further session approximately 4 months later with additional telephone support.
Intervention typeOther
Primary outcome measureSocial functioning as measured by the Social Functioning Questionnaire (SFQ). This is an 8-item self-report scale, each item scored on a scale from 0 to 3. A reduction (i.e. an improvement) of 2 points or more on the SFQ at 1 year, post-treatment follow-up is the specified clinically significant change.
Secondary outcome measures1. Receipt and cost of services post-therapy and at one year follow-up measured by the Client Service Receipt Inventory
2. Scheduled and unscheduled service use post-therapy and at one year follow-up measured by the Client Service Receipt Inventory and a service use record check.
3. Quality of life post-therapy and at one year follow-up measured by the EQ-5D
4. Referrer's ratings of functioning post-therapy and at one year follow-up measured by the Global Assessment of Functioning
5. Anxiety and depression post-therapy and at one year follow-up meaured by the Hospital Anxiety and Depression Scale
6. A rating of the client's self-assessment of problems post-therapy and at one year follow-up
Overall study start date01/08/2010
Completion date31/01/2014

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants340
Key inclusion criteria1. Living in the community
2. Presence of one or more personality disorder, as identified by the International Personality Disorder Examination
3. Aged 18 years or over, either sex
4. Proficiency in spoken English is necessary for trial participation due to the requirements of the interventions used
5. Capacity to provide valid informed consent
Key exclusion criteriaCurrent exclusion criteria as of 23/06/2011:
1. Primary diagnosis of major functional psychosis
2. Insufficient degree of literacy, comprehension or attention to be able to engage in trial therapy and assessments
3. Currently engaged in psychological treatment for personality disorder, or likely to start such treatment during the trial period
4. Already enrolled in any other trial

Previous exclusion criteria:
1. Insufficient degree of literacy, comprehension or attention to be able to engage in trial therapy and assessments, as assessed by the Investigator or authorised designee in conjunction with the participants usual care team. This may be a result of psychosis, developmental disability, organic brain disorder, substance use, or any other disorder or disability.
2. Currently engaged in psychological treatment for personality disorder, or likely to start such treatment during the trial period
3. Already enrolled in any other trial
Date of first enrolment01/08/2010
Date of final enrolment31/01/2014

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Institute of Mental Health
Nottingham
NG7 2TU
United Kingdom

Sponsor information

Nottinghamshire Healthcare NHS Trust (UK)
Hospital/treatment centre

Duncan MacMillan House
Porchester Road
Mapperley
Nottingham
NG3 6AA
England
United Kingdom

Website http://www.nottinghamshirehealthcare.nhs.uk/
ROR logo "ROR" https://ror.org/04ehjk122

Funders

Funder type

Government

NIHR Health Technology Assessment Programme - HTA (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 24/08/2011 Yes No
Results article results 01/07/2016 Yes No

Editorial Notes

16/01/2018: internal review.
21/07/2016: Publication reference added.